Analyse @AlbertBourla's tweets
@AlbertBourla
| 58,583 followers
Early data from our trial evaluating our Omicron BA.4/BA.5-adapted #COVID19 vaccine show increased neutralizing antibodies compared to our Original monovalent vaccine, suggesting it could potentially provide better protection against Omicron BA.4/BA.5: https://t.co/rh3wae5zVM https://t.co/GVfmJQ2AKl